Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (A danish organization for randomized trials on clinical outcome III substudy)

American Journal of Cardiology

Volumn 115, Issue 3, 2015, Pages 298-302

  Olesen, Kevin K W ^a   Tilsted, Hans Henrik ^b   Jensen, Lisette O ^c   Kaltoft, Anne ^a   Krusell, Lars R ^a   Ravkilde, Jan ^b   Christiansen, Evald H ^a   Madsen, Morten ^b   Thayssen, Per ^c   Sørensen, Henrik T ^b   Lassen, Jens F ^a   Maeng, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; ZOTAROLIMUS;

ARTICLE; CAUSE OF DEATH; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; STENT THROMBOSIS; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BLOOD VESSEL TRANSPLANTATION; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GRAFT OCCLUSION; MALE; MULTICENTER STUDY; PROCEDURES; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RESTENOSIS; THROMBOSIS;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; REOPERATION; SIROLIMUS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84920748788     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.10.038     Document Type: Article

References (17)

1. M. Maeng, L.O. Jensen, H.H. Tilsted, A. Kaltoft, H. Kelbaek, U. Abildgaard, A. Villadsen, J. Aaroe, P. Thayssen, L.R. Krusell, E.H. Christiansen, H.E. Botker, S.D. Kristensen, J. Ravkilde, M. Madsen, H.T. Sorensen, K. Rasmussen, L. Thuesen, and J.F. Lassen Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy) Am J Cardiol 108 2011 1232 1237
2. C. Briguori, F. Airoldi, G. Visconti, A. Focaccio, G. Caiazzo, B. Golia, G. Biondi-Zoccai, B. Ricciardelli, and G. Condorelli Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients Circ Cardiovasc Interv 4 2011 121 129
3. S. Bangalore, S. Kumar, M. Fusaro, N. Amoroso, A.J. Kirtane, R.A. Byrne, D.O. Williams, J. Slater, D.E. Cutlip, and F. Feit Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials BMJ 345 2012 e5170
4. M. Maeng, H.H. Tilsted, L.O. Jensen, A. Kaltoft, H. Kelbaek, U. Abildgaard, A.B. Villadsen, L.R. Krusell, J. Ravkilde, K.N. Hansen, E.H. Christiansen, J. Aaroe, J.S. Jensen, S.D. Kristensen, H.E. Botker, M. Madsen, P. Thayssen, H.T. Sorensen, L. Thuesen, and J.F. Lassen 3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents JACC Cardiovasc Interv 5 2012 812 818
5. K. Rasmussen, M. Maeng, A. Kaltoft, P. Thayssen, H. Kelbaek, H.H. Tilsted, U. Abildgaard, E.H. Christiansen, T. Engstrom, L.R. Krusell, J. Ravkilde, P.R. Hansen, K.N. Hansen, S.Z. Abildstrom, J. Aaroe, J.S. Jensen, S.D. Kristensen, H.E. Botker, M. Madsen, S.P. Johnsen, L.O. Jensen, H.T. Sorensen, L. Thuesen, and J.F. Lassen Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial Lancet 375 2010 1090 1099
6. M. Maeng, H.H. Tilsted, L.O. Jensen, L.R. Krusell, A. Kaltoft, H. Kelbaek, A.B. Villadsen, J. Ravkilde, K.N. Hansen, E.H. Christiansen, J. Aaroe, J.S. Jensen, S.D. Kristensen, H.E. Botker, L. Thuesen, M. Madsen, P. Thayssen, H.T. Sorensen, and J.F. Lassen Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial Lancet 383 2014 2047 2056
7. L.O. Jensen, M. Maeng, P. Thayssen, A. Villadsen, L. Krusell, H.E. Botker, K.E. Pedersen, J. Aaroe, E.H. Christiansen, T. Vesterlund, K.N. Hansen, J. Ravkilde, H.H. Tilsted, J.F. Lassen, and L. Thuesen Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial EuroIntervention 7 2011 323 331
8. A.J. Kirtane, M.B. Leon, M.W. Ball, H.S. Bajwa, M.H. Sketch Jr., P.S. Coleman, R.C. Stoler, S. Papadakos, D.E. Cutlip, L. Mauri, and D.E. Kandzari The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent JACC Cardiovasc Interv 6 2013 325 333
9. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
10. L.O. Jensen, P. Thayssen, A. Junker, M. Maeng, H.H. Tilsted, A. Kaltoft, K.N. Hansen, E.H. Christiansen, S.D. Kristensen, J. Ravkilde, M. Madsen, H.T. Sorensen, L. Thuesen, and J.F. Lassen Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial) Am J Cardiol 110 2012 1585 1591
11. M. Vardi, D.A. Burke, S. Bangalore, M.J. Pencina, L. Mauri, D.E. Kandzari, M.B. Leon, and D.E. Cutlip Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials Catheter Cardiovasc Interv 82 2013 1031 1038
12. P. Wenaweser, J. Daemen, M. Zwahlen, D.R. van, P. Juni, S. Vaina, G. Hellige, K. Tsuchida, C. Morger, E. Boersma, N. Kukreja, B. Meier, P.W. Serruys, and S. Windecker Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
13. R.A. Byrne, A. Kastrati, K. Tiroch, S. Schulz, J. Pache, S. Pinieck, S. Massberg, M. Seyfarth, K.L. Laugwitz, K.A. Birkmeier, A. Schomig, and J. Mehilli 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents J Am Coll Cardiol 55 2010 2536 2543
14. R.A. Byrne, J. Mehilli, R. Iijima, S. Schulz, J. Pache, M. Seyfarth, A. Schomig, and A. Kastrati A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents Eur Heart J 30 2009 923 931
15. D.E. Kandzari, L. Mauri, J.J. Popma, M.A. Turco, P.A. Gurbel, P.J. Fitzgerald, and M.B. Leon Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-Year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions) JACC Cardiovasc Interv 4 2011 543 550
16. W. Wijns, P.G. Steg, L. Mauri, V. Kurowski, K. Parikh, R. Gao, C. Bode, J.P. Greenwood, E. Lipsic, F. Alamgir, T. Rademaker-Havinga, E. Boersma, P. Radke, L.F. Van, and E. Camenzind Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4 year results of the PROTECT randomized trial Eur Heart J 35 2014 2812 2820
17. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, C. Stettler, D. Sangiorgi, F. D'Ascenzo, T. Kimura, C. Briguori, M. Sabatè, H.S. Kim, A. De Waha, E. Kedhi, P.C. Smits, C. Kaiser, G. Sardella, A. Marullo, A.J. Kirtane, M.B. Leon, and G.W. Stone Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402